Clinical Trial

Cohort Study to Refine the Positioning of Closed-loop Therapy Versus Islet Transplantation in the Management of Patients With Unstable Type 1 Diabetes

Study acronym: STABILOOP
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, multicenter, descriptive cohort (RIPH3 study under the Jardé Act), STABILOOP study aims to describe whether BF may be an appropriate therapeutic option for the cohort of patients who are theoretically candidates for Islet transplantation, by describing Closed-Loop failures at 12 months in patients referred to an expert center for management of unstable diabetes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-27.
Status change: Not Yet Recruiting → Recruiting 2025-07-25
Trial Details
NCT Number NCT07006272
Lead Sponsor University Hospital, Grenoble
Conditions Type 1 Diabetes (T1D)
Enrollment 35 participants
Start Date 2025-06-04
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-28